Anaesthesia Drugs Market Forecasts to 2028 - Global Analysis By Route of Administration (Injection Anesthesia Drugs, Inhalation Anesthesia Drugs, Intravenous Anesthesia Drugs, Topical Anesthesia Drugs), Anaesthesia Type (Regional Anesthesia, Local Anesthesia, General Anesthesia, Sedation), Drug Type (Local Anesthesia Drugs, General Anesthesia Drugs), Application (Plastic Surgery, Dental Surgery, General Surgery, Cosmetic Surgery), End User (Specialty Clinics, Hospitals, Ambulatory Surgical Centers, Pharmaceutical Companies), and By Geography
Estimated Year Value (2022)
US $7.58 BN
Projected Year Value (2028)
US $10.52 BN
CAGR (2022 - 2028)
North America, Europe, Asia Pacific, South America, and Middle East & Africa
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa
Fastest Growing Market
According to Stratistics MRC, the Global Anaesthesia Drugs Market is accounted for $7.58 billion in 2022 and is expected to reach $10.52 billion by 2028 growing at a CAGR of 5.6% during the forecast period. Anaesthesia is a medical procedure that allows patients to be pain-free during surgery. Anaesthetics are administered by injection, inhalation, topical lotion, spray, eye drops, or a skin patch, depending on the type of pain relief required. The use of anesthesia drugs causes a momentary loss of feeling or awareness. They are split into two categories such as general anesthetics, which produce a reversible loss of consciousness, and local anesthetics, which cause a reversible loss of feeling for a specific area of the body but do not impact consciousness. During surgery, anesthesia medication is used to alleviate discomfort. Depending on the surgery and the patient’s health, several types and degrees of anesthesia may be used. New technology (such as wireless communication) has helped to enhance anesthesia distribution and patient monitoring during surgeries.
According to the American Society of Plastic Surgeons, in 2020, 2.3 million cosmetic surgical procedures, 13.2 million cosmetic minimally invasive procedures, and 6.8 million reconstructive procedures were performed in the United States 2020, representing a 3% increase over 2019. This indicates the rising number of surgeries, which ultimately results in the rising demand for anesthesia drugs. Moreover, according to the article 'Trauma of Major Surgery' published in the National Center for Biotechnology Information (NCBI) in July 2020, globally, a staggering 310 million major surgeries are performed each year. Similarly, according to the article titled 'Incidence and Cumulative Risk of Major Surgery in Older Persons in the United States published in July 2021, in the United States, Nearly nine major surgeries were performed annually for every 100 older persons, and more than 1 in 7 Medicare beneficiaries underwent a major surgery over five years, representing nearly 5 million unique older people.
Growing number of surgeries, rising elderly population and advances in technology
One of the major factors driving the anaesthetics market is the increase in the number of surgeries performed that use anaesthetics during the surgical procedure. An increase in surgeries is primarily due to the increasing incidents of traumatic injuries and accidents requiring surgical procedures. World Health Organization's Global status report on road safety 2018 shows that there are 1.35 million road accidents every year, with 64 deaths per 100,000 vehicles. Additionally, advances in technology in the delivery of Drugs, the development of specifically targeted medicines, the development of devices to monitor patients' physiological parameters during and after Anesthesia, and reduced side effects of anaesthetics are the driving factors that will boost the market growth. By 2050, one out of four people living in Europe and Northern America could be 65 years or older, according to the Department of Economic and Social Affairs of the United Nations. With an increase in the elderly population, chronic diseases such as cardiovascular and neurological are on the rise in older populations, further increasing the need for Anesthesia Drugs.
Adverse effects of anesthetic drugs
The side effects of anesthetic drugs during and after surgery are predicted to restrain the market growth in the future. Common side effects observed are ringing in the ears, dizziness, numbness, twitching, and a metallic taste. In extreme cases, it can cause seizures, low blood pressure, slowed heart rate, and breathing problems. Most people will not experience any long-term side effects. However, geriatric populations are more prone to side effects that last longer than a few days. Side effects are high if the patient has certain pre-existing conditions such as reactions to anesthesia, sleep apnea, seizures, obesity, high blood pressure, diabetes, heart disease, lung disease, kidney disease, or drug allergies. Additionally, side effects such as nausea, vomiting, pruritus, urinary retention, sedation, and delayed respiratory depression can occur. Unintended intraoperative awareness is another consequence, in rare cases where patients report a state of awareness during the surgery, after the point where the anesthetic should cause numbness or no sensation. Some patients are conscious during the procedure, and some may even feel pain. Thus, after the surgery, patients may suffer from pain. The duration of action of these drugs can be prolonged both by increasing the dose and by a continuous infusion of the drug, leading to dose-dependent effects on the cardiovascular system and/or central nervous system (CNS).
Increasing technological advancements
The surging number of surgical procedures globally is predicted to provide opportunities to the market during the forecast period. There are innovative and technological advancements in anesthetics, which accelerate the market growth. However, the future of the market is challenging owing to stagnant reimbursement procedures, the command for safety and quality, and claims on the evidence to drive the practice. As per the research article published in the Journal of Anesthesia 2019, the emergence of ultrasound-guided regional anesthesia has soared rapid growth in various nerve block techniques, with for inter fascial plane blocks. However, only numerous anesthetists may know these novel blocks, while the remainder may see regional anesthesia becoming too complex and intimidating. Hence, training sessions for the anesthetists will be required, playing a fundamental role in enhancing the use of anesthetic drugs in the future. Furthermore, according to the research article published in the Saudi Journal of Anesthesia, 2020, adjuvants to local anesthetics are budding in anesthesiology, where newer agents and techniques are added to develop the efficacy and safety of analgesia used. Research continues on agents capable of prolonging the effect of local anesthetics without neurotoxicity or deleterious effects. Robotic anesthesia has attracted many manufacturers due to its potential to deliver manual gestures with precision.
Unintentional intraoperative awareness
During the surgical process when general Anesthesia is given, approximately one or two people out of every 1000 may be unaware that they are partially awake. There is very little chance of experiencing pain, but this can also occur. Since people are being given relaxation Drugs before surgeries, they cannot move or communicate their pain or awareness to the doctors. There is the possibility that this will cause patients long-term psychological problems, similar to post-traumatic stress disorder. This is called unintentional intraoperative awareness and it is one of the major challenges to the Anesthesia drugs market.
A slight decline in the demand for anesthesia drugs was observed in 2020 as a result of the pandemic, causing delays or cancellations of surgeries. According to a study published in the British Journal of Surgery, approximately 28.4 million elective surgeries were cancelled or postponed globally in May 2020 due to the disruption of hospital services caused by COVID-19. Nevertheless, as social activities are resuming, all elective surgeries that were delayed, are being performed now, which means that anesthesia drugs are being consumed in greater quantities resulting in the market gradually picking up market growth. Post covid 19, the need for anesthesia drugs will grow more.
The general anesthesia drugs segment is expected to be the largest during the forecast period
The general anesthesia drugs segment is anticipated to have a lucrative growth, due to increase in the number of general and emergency surgeries which require the use of general anesthesia drugs since they helped doctors to create individualized anaesthetic plans that balance the patient's history with the anticipated surgical plan that maximizes patient safety.
The intravenous anesthesia drugs segment is expected to have the highest CAGR during the forecast period
The intravenous anesthesia drugs segment is anticipated to witness the fastest CAGR growth during the forecast period, as it offers various advantages such as more accurate dose delivery, better patient safety, lower rates of (postoperative nausea, vomiting, urinary retention, and malignant hyperthermia (a rare but serious side effect of general Anesthesia)), reduced risk of blood clots and pulmonary emboli (blood clots that move to the lungs). Furthermore, intravenous anesthesia medicines can be more precise which amounts to a higher safety level.
Region with highest share:
North America is projected to have the largest market share during the forecast period, due to increasing aging population with growing chronic conditions, rising number of surgeries, and advancements in anesthesia technologies. The United States is the largest regional market in the world. With the emergence of COVID-19, the United States faced heavy shortages of vital anesthesia drugs, particularly dexmedetomidine, midazolam, propofol, and neuromuscular blocking agents. As a result, many companies are ramping up their production of anesthesia drugs. Around 40-50 million out of 310 million major surgeries worldwide are performed every year in the United States alone.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to the rapidly expanding healthcare infrastructure, the presence of major players, the adoption of anesthesia drugs is increasing rapidly in this region, increasing cases of chronic diseases, load of the aging population, and related diseases increasing the procurement of local anesthetics for surgery and management of postoperative pain.
Key players in the market
Some of the key players profiled in the Anaesthesia Drugs Market include F. Hoffmann-La Roche Ltd, Fresenius SE & Co. KGaA, AbbVie Inc, Pfizer Inc., Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories, Baxter International, Inc., Novartis AG, Abbott Laboratories, B. Braun Melsungen AG, Astrazeneca PLC, GlaxoSmithKline plc, Hikma Pharmaceuticals PLC, Piramal Enterprises Limited, Teva Pharmaceutical Industries Limited, Mylan NV, Johnson & Johnson, Merck, and Eisai Inc.
In July 2021, Hikma Pharmaceuticals PLC (Hikma), an international pharma company, launched Succiniylcholine Chloride Injection, USP 20mg/mL in the US, through its US affiliate, Hikma Pharmaceuticals USA Inc. In the treatment of COVID-19 patients Succinylcholine Chloride Injection, USP plays an important role. It is used to facilitate tracheal intubation as well as to relax skeletal muscles during a procedure or while on mechanical ventilation.
In November 2020, Pfizer announced the completion of merging its Upjohn business with Mylan N.V. to form Viatris Inc., where Pfizer would hold 57% of the shares of the company.
In August 2020, Teva Pharmaceuticals announced a strategic partnership with a biopharmaceutical company called Alvotech for the commercialization of five biosimilar products in the United States.
In August 2020, B. Braun and Royal Philips announced that their Onvision needle tip tracking technology for regional anesthesia got the 501(k) clearance from the United States Food and Drug Administration.
Route of Administrations Covered:
• Injection Anesthesia Drugs
• Inhalation Anesthesia Drugs
• Intravenous Anesthesia Drugs
• Topical Anesthesia Drugs
Anaesthesia Types Covered:
• Regional Anesthesia
• Local Anesthesia
• General Anesthesia
Drug Types Covered:
• Local Anesthesia Drugs
• General Anesthesia Drugs
• Plastic Surgery
• Dental Surgery
• General Surgery
• Cosmetic Surgery
End Users Covered:
• Specialty Clinics
• Ambulatory Surgical Centers
• Pharmaceutical Companies
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
3 Market Trend Analysis
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Anaesthesia Drugs Market, By Route of Administration
5.2 Injection Anesthesia Drugs
5.3 Inhalation Anesthesia Drugs
5.4 Intravenous Anesthesia Drugs
5.5 Topical Anesthesia Drugs
6 Global Anaesthesia Drugs Market, By Anaesthesia Type
6.2 Regional Anesthesia
6.3 Local Anesthesia
6.4 General Anesthesia
7 Global Anaesthesia Drugs Market, By Drug Type
7.2 Local Anesthesia Drugs
7.3 General Anesthesia Drugs
7.3.4 Propofol (Diprivan)
7.3.9 Nitrous Oxide
7.3.10 Methohexital Sodium
8 Global Anaesthesia Drugs Market, By Application
8.2 Plastic Surgery
8.3 Dental Surgery
8.4 General Surgery
8.5 Cosmetic Surgery
9 Global Anaesthesia Drugs Market, By End User
9.2 Specialty Clinics
9.4 Ambulatory Surgical Centers
9.5 Pharmaceutical Companies
10 Global Anaesthesia Drugs Market, By Geography
10.2 North America
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.5 Other Key Strategies
12 Company Profiling
12.1 F. Hoffmann-La Roche Ltd Baxter
12.2 Fresenius SE & Co. KGaA
12.3 AbbVie Inc
12.4 Pfizer Inc.
12.5 Boehringer Ingelheim International GmbH
12.6 Dr. Reddy's Laboratories
12.7 Baxter International, Inc.
12.8 Novartis AG
12.9 Abbott Laboratories
12.10 B. Braun Melsungen AG
12.11 Astrazeneca PLC
12.12 GlaxoSmithKline plc
12.13 Hikma Pharmaceuticals PLC
12.14 Piramal Enterprises Limited
12.15 Teva Pharmaceutical Industries Limited
12.16 Mylan NV
12.17 Johnson & Johnson
12.19 Eisai Inc.
List of Tables
1 Global Anaesthesia Drugs Market Outlook, By Region (2020-2028) ($MN)
2 Global Anaesthesia Drugs Market Outlook, By Route of Administration (2020-2028) ($MN)
3 Global Anaesthesia Drugs Market Outlook, By Injection Anesthesia Drugs (2020-2028) ($MN)
4 Global Anaesthesia Drugs Market Outlook, By Inhalation Anesthesia Drugs (2020-2028) ($MN)
5 Global Anaesthesia Drugs Market Outlook, By Intravenous Anesthesia Drugs (2020-2028) ($MN)
6 Global Anaesthesia Drugs Market Outlook, By Topical Anesthesia Drugs (2020-2028) ($MN)
7 Global Anaesthesia Drugs Market Outlook, By Anaesthesia Type (2020-2028) ($MN)
8 Global Anaesthesia Drugs Market Outlook, By Regional Anesthesia (2020-2028) ($MN)
9 Global Anaesthesia Drugs Market Outlook, By Local Anesthesia (2020-2028) ($MN)
10 Global Anaesthesia Drugs Market Outlook, By General Anesthesia (2020-2028) ($MN)
11 Global Anaesthesia Drugs Market Outlook, By Sedation (2020-2028) ($MN)
12 Global Anaesthesia Drugs Market Outlook, By Drug Type (2020-2028) ($MN)
13 Global Anaesthesia Drugs Market Outlook, By Local Anesthesia Drugs (2020-2028) ($MN)
14 Global Anaesthesia Drugs Market Outlook, By Ropivacaine (2020-2028) ($MN)
15 Global Anaesthesia Drugs Market Outlook, By Chloroprocaine (2020-2028) ($MN)
16 Global Anaesthesia Drugs Market Outlook, By Benzocaine (2020-2028) ($MN)
17 Global Anaesthesia Drugs Market Outlook, By Prilocaine (2020-2028) ($MN)
18 Global Anaesthesia Drugs Market Outlook, By Bupivacaine (2020-2028) ($MN)
19 Global Anaesthesia Drugs Market Outlook, By Lidocaine (2020-2028) ($MN)
20 Global Anaesthesia Drugs Market Outlook, By Articaine (2020-2028) ($MN)
21 Global Anaesthesia Drugs Market Outlook, By General Anesthesia Drugs (2020-2028) ($MN)
22 Global Anaesthesia Drugs Market Outlook, By Sevoflurane (2020-2028) ($MN)
23 Global Anaesthesia Drugs Market Outlook, By Dexmedetomidine (2020-2028) ($MN)
24 Global Anaesthesia Drugs Market Outlook, By Midazolam (2020-2028) ($MN)
25 Global Anaesthesia Drugs Market Outlook, By Propofol (Diprivan) (2020-2028) ($MN)
26 Global Anaesthesia Drugs Market Outlook, By Remifentanil (2020-2028) ($MN)
27 Global Anaesthesia Drugs Market Outlook, By Desflurane (2020-2028) ($MN)
28 Global Anaesthesia Drugs Market Outlook, By Isoflurane (2020-2028) ($MN)
29 Global Anaesthesia Drugs Market Outlook, By Ketamine (2020-2028) ($MN)
30 Global Anaesthesia Drugs Market Outlook, By Nitrous Oxide (2020-2028) ($MN)
31 Global Anaesthesia Drugs Market Outlook, By Methohexital Sodium (2020-2028) ($MN)
32 Global Anaesthesia Drugs Market Outlook, By Benzodiazepines (2020-2028) ($MN)
33 Global Anaesthesia Drugs Market Outlook, By Application (2020-2028) ($MN)
34 Global Anaesthesia Drugs Market Outlook, By Plastic Surgery (2020-2028) ($MN)
35 Global Anaesthesia Drugs Market Outlook, By Dental Surgery (2020-2028) ($MN)
36 Global Anaesthesia Drugs Market Outlook, By General Surgery (2020-2028) ($MN)
37 Global Anaesthesia Drugs Market Outlook, By Cosmetic Surgery (2020-2028) ($MN)
38 Global Anaesthesia Drugs Market Outlook, By End User (2020-2028) ($MN)
39 Global Anaesthesia Drugs Market Outlook, By Specialty Clinics (2020-2028) ($MN)
40 Global Anaesthesia Drugs Market Outlook, By Hospitals (2020-2028) ($MN)
41 Global Anaesthesia Drugs Market Outlook, By Ambulatory Surgical Centers (2020-2028) ($MN)
42 Global Anaesthesia Drugs Market Outlook, By Pharmaceutical Companies (2020-2028) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Frequently Asked Questions
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: firstname.lastname@example.org or phone: +1-301-202-5929
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at email@example.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.